Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on April 14, 2025

Can-Fite Reports 2024 Financial Results and Clinical Update
RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today …

Safe & Green Holdings Corp. Announces Pricing of Approximately $8.0 Million Private Placement
MIAMI, April 14, 2025 (GLOBE NEWSWIRE) -- Safe …

Impacful LLC Unveils Kairos IMS: Revolutionizing Health and Human Services Nonprofits
"Kairos IMS redefines the future for nonprofits, empowering them with cutting-edge tools to fuel social impact and transform community care like never before." FORT LAUDERDALE, FL, UNITED STATES, April 13, 2025 /EINPresswire.com/ -- On April 29th, …

Wrapsody eCo Strengthens Data Protection and Secure Collaboration Across Diverse Industries
SEOUL, SOUTH KOREA, April 14, 2025 /EINPresswire.com/ -- As organizations across industries increasingly rely on digital collaboration, the need for secure and efficient document management has never been greater. Fasoo’s next-generation secure …

InVivo Biosystems Advances AI Technology for Real Time Animal Health Monitoring
InVivo Biosystems announces acquisition of SBIR Phase II funding for AI-Powered Animal Health Monitoring Technology EUGENE, OR, UNITED STATES, April 13, 2025 /EINPresswire.com/ -- InVivo Biosystems, a leader in zebrafish research solutions, is proud to …

Unisize, a sizing recommendation software for fashion apparel e-commerce, releases a new demo of “FaceChange” AI Function
LONDON, April 14, 2025 (GLOBE NEWSWIRE) -- Makip London., Ltd. has updated its sizing recommendation software - Unisize - and released a new feature that allows online shoppers to replace the facial features of the online model with their own face, …

ASML reports transactions under its current share buyback program
ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average …

STMicroelectronics Announces Status of Common Share Repurchase Program
STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from Apr 07, 2025 to Apr 11, 2025 AMSTERDAM – April 14, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a …

TopBuilder Announces Integration With BuildingConnected
HOUSTON, April 14, 2025 (GLOBE NEWSWIRE) -- TopBuilder, a leading business development platform and CRM software for contractors in commercial construction, is excited to announce a new integration with BuildingConnected®, a pre-construction solution that …

INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom™ Manufacturing for Commercial Readiness
Stevenage, UK, and Boca Raton, Florida, US, April 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system has partnered with the Cell and …

Enviri Corporation Announces Timing of First Quarter 2025 Results and Conference Call
PHILADELPHIA, April 14, 2025 (GLOBE NEWSWIRE) -- Enviri Corporation (NYSE: NVRI) today announced that it will issue its first quarter 2025 earnings results on Thursday, May 1, 2025 prior to NYSE market open. The Company will also host its quarterly …

Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products
FLORHAM PARK, N.J., April 14, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, welcomes action by the Centers for Medicare …

NKGen Biotech To Present on the Use of Troculeucel for Alzheimer’s and Parkinson’s Disease at the 7th China International Biotechnology Conference & Exhibition
SANTA ANA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …

HealthLynked Welcomes Anthony Scuilla as Sales Consultant to Drive Strategic Partnerships with Insurance Providers
NAPLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- HealthLynked Corp. (OTCQB: HLYK), a leader in healthcare technology innovation, is proud to announce the appointment of Anthony "Tony" Scuilla as a strategic sales consultant. In his new role, Mr. …

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
BOSTON and ATLANTA, April 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company innovating small molecule kinase inhibitor therapeutics to treat pulmonary arterial …

FOREWARN to Provide Identity Verification Services to HiCentral MLS® to Promote Agent Safety
BOCA RATON, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- FOREWARN, LLC, a red violet company (NASDAQ: RDVT) and the leading provider of real-time information solutions for real estate agents, today announced that HiCentral MLS® will offer FOREWARN® services to …

CBAK Partners with Kandi to Localize Lithium Battery Facilities in the U.S. in Phases
DALIAN, China, April 14, 2025 (GLOBE NEWSWIRE) -- CBAK Energy Technology, Inc. (NASDAQ: CBAT) (“CBAK Energy,” or the “Company”) a leading lithium-ion battery manufacturer and electric energy solution provider in China, jointly with Kandi Technologies Group …

MKS Instruments Announces First Quarter 2025 Earnings Conference Call
ANDOVER, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release first quarter 2025 financial results after market …

Fate Therapeutics Receives Regenerative Medicine Advanced Therapy (RMAT) Designation from FDA for FT819 to Treat Moderate to Severe Systemic Lupus Erythematosus (SLE)
– Recognizes potential of off-the-shelf CAR T-cell therapy to address significant unmet need and enables increased dialogue with FDA throughout the development process – RMAT review by FDA included initial clinical safety and activity data from ongoing …

Coherus Completes Strategic Transformation with Successful Divestiture of UDENYCA® Franchise
– $250 million post-close cash balance extends cash runway over two years into 2027, funding pipeline development through key data catalysts – – Coherus to focus exclusively on its innovative novel oncology programs including: – LOQTORZI®, a revenue- …